Clinical Applications of PET Imaging in Alzheimer's Disease

被引:4
作者
Patil, Shiv [1 ,2 ]
Ayubcha, Cyrus [3 ,4 ]
Teichner, Eric [1 ,2 ]
Subtirelu, Robert [1 ]
Cho, Julia H. [3 ]
Ghonim, Mohanad [1 ,5 ]
Ghonim, Mohamed [1 ,5 ]
Werner, Thomas J. [1 ]
Flemming, Poul
Hoilund-Carlsen, Poul Flemming [6 ]
Alavi, Abass [1 ]
Newberg, Andrew B. [7 ,8 ]
机构
[1] Hosp Univ Penn, Dept Radiol, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19144 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[5] Ain Shams Univ, Dept Radiol, Cairo, Egypt
[6] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[7] Thomas Jefferson Univ, Marcus Inst Integrat Hlth, Philadelphia, PA 19107 USA
[8] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA
关键词
Alzheimer's disease; Mild cognitive impairment; Amyloid; Positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ADRDA WORK GROUP; AMYLOID PET; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; GLUCOSE-METABOLISM; APOE GENOTYPE; BRAIN;
D O I
10.1016/j.cpet.2024.09.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PET imaging has been instrumental in investigating and evaluating the complete disease process of AD. Recent innovations in tracer development, artificial intelligence techniques, and -omics models have further elevated the value of PET inAD.114Expanding on this role, PET techniques are likely to remain crucial in uncovering AD's path-ophysiology, managing the disease clinically, and designing and assessing therapeutic strategies targeting AD pathology.
引用
收藏
页码:89 / 100
页数:12
相关论文
共 115 条
[1]   Provisional Mortality Data - United States, 2022 [J].
Ahmad, Farida B. ;
Cisewski, Jodi A. ;
Xu, Jiaquan ;
Anderson, Robert N. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (18) :488-492
[2]   The conception of FDG-PET imaging [J].
Alavi, A ;
Reivich, M .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (01) :2-5
[3]  
ALAVI A, 1993, J NUCL MED, V34, P1681
[4]   Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach [J].
Alavi, Abass ;
Barrio, Jorge R. ;
Werner, Thomas J. ;
Khosravi, Mohsen ;
Newberg, Andrew ;
Hoilund-Carlsen, Poul Flemming .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (02) :225-230
[5]   Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging [J].
Albin, Roger L. ;
Burke, James F. ;
Koeppe, Robert A. ;
Giordani, Bruno ;
Gilman, Sid ;
Frey, Kirk A. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) :887-893
[6]   Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials [J].
Andrews, J. Scott ;
Desai, Urvi ;
Kirson, Noam Y. ;
Zichlin, Miriam L. ;
Ball, Daniel E. ;
Matthews, Brandy R. .
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) :354-363
[7]  
Association as, 2024, Alzheimer's disease facts and figures: prevalence
[8]   Machine learning in the positron emission tomography imaging of Alzheimer's disease [J].
Ayubcha, Cyrus ;
Singh, Shashi B. ;
Patel, Krishna H. ;
Rahmim, Arman ;
Hasan, Jareed ;
Liu, Litian ;
Werner, Thomas ;
Alavi, Abass .
NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (09) :751-766
[9]   Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study [J].
Barthel, Henryk ;
Gertz, Hermann-Josef ;
Dresel, Stefan ;
Peters, Oliver ;
Bartenstein, Peter ;
Buerger, Katharina ;
Hiemeyer, Florian ;
Wittemer-Rump, Sabine M. ;
Seibyl, John ;
Reininger, Cornelia ;
Sabri, Osama .
LANCET NEUROLOGY, 2011, 10 (05) :424-435
[10]   LOSS OF BRAIN 5-HT(2) RECEPTORS IN ALZHEIMERS-DISEASE - IN-VIVO ASSESSMENT WITH POSITRON EMISSION TOMOGRAPHY AND [F-18] SETOPERONE [J].
BLIN, J ;
BARON, JC ;
DUBOIS, B ;
CROUZEL, C ;
FIORELLI, M ;
ATTARLEVY, D ;
PILLON, B ;
FOURNIER, D ;
VIDAILHET, M ;
AGID, Y .
BRAIN, 1993, 116 :497-510